Cargando…
Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
Medication-related osteonecrosis of the jaw (MRONJ) was first reported more than a decade ago. Since then, numerous cases have been diagnosed. Currently, there are three groups of drugs related to MRONJ: bisphosphonates, denosumab and anti-angiogenic drugs. As MRONJ can lead to debilitating clinical...
Autor principal: | Wat, Winnie Zee Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806951/ https://www.ncbi.nlm.nih.gov/pubmed/29563480 http://dx.doi.org/10.3390/dj4040038 |
Ejemplares similares
-
Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw
por: He, Lina, et al.
Publicado: (2020) -
Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Ascani, Giuliano, et al.
Publicado: (2014) -
Current perspectives on bisphosphonate treatment in Paget’s disease of bone
por: Wat, Winnie Zee Man
Publicado: (2014) -
Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022) -
Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023)